Hoos Axel 4
4 · TCR2 THERAPEUTICS INC. · Filed Dec 11, 2020
Insider Transaction Report
Form 4
Hoos Axel
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-12-10+12,100→ 12,100 totalExercise: $31.83Exp: 2030-12-09→ Common Stock (12,100 underlying)
Footnotes (1)
- [F1]25% of this option shall vest and become exercisable on January 1, 2022, with the remainder vesting in twenty-four (24) equal monthly installments thereafter.